Cyproheptadine Hydrochloride and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Cyproheptadine Hydrochloride and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyproheptadine
Brand name: Periactin
Synonyms: Cyproheptadine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyproheptadine Hydrochloride-Insulin degludec
- Cyproheptadine Hydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Cyproheptadine Hydrochloride-Insulin Degludec (U-100) Vials
- Cyproheptadine Hydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Cyproheptadine Hydrochloride-Insulin degludec and liraglutide
- Cyproheptadine Hydrochloride-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Cyproheptadine Solution
- Insulin aspart, recombinant Subcutaneous-Cyproheptadine Syrup
- Insulin aspart, recombinant Subcutaneous-Cyproheptadine Tablets
- Insulin aspart, recombinant Subcutaneous-Cyramza
- Insulin aspart, recombinant Subcutaneous-Cyred
- Insulin aspart, recombinant Subcutaneous-Cyred EQ